Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) FCF Margin (2024 - 2026)

Beta Bionics' FCF Margin history spans 3 years, with the latest figure at 91.25% for Q1 2026.

  • On a quarterly basis, FCF Margin rose 2388.0% to 91.25% in Q1 2026 year-over-year; TTM through Mar 2026 was 55.45%, a 2965.0% increase, with the full-year FY2025 number at 56.08%, up 2326.0% from a year prior.
  • FCF Margin hit 91.25% in Q1 2026 for Beta Bionics, down from 43.23% in the prior quarter.
  • Over the last five years, FCF Margin for BBNX hit a ceiling of 31.8% in Q3 2025 and a floor of 115.13% in Q1 2025.
  • Historically, FCF Margin has averaged 73.59% across 3 years, with a median of 72.6% in 2024.
  • The widest YoY moves for FCF Margin: up 3699bps in 2025, down -1809bps in 2025.
  • Tracing BBNX's FCF Margin over 3 years: stood at 72.6% in 2024, then skyrocketed by 40bps to 43.23% in 2025, then tumbled by -111bps to 91.25% in 2026.
  • Business Quant data shows FCF Margin for BBNX at 91.25% in Q1 2026, 43.23% in Q4 2025, and 31.8% in Q3 2025.